Bullish
@matador1 @BTechPimp early stage bio. PTI-428 they were unsure of the dosing, it has the potential to create multiple mutations compared to others than only has one mutation which allows PTI-428 able to almost double the total amount of functional CFTR protein being produced. 👇 Bios in early stage can be torn apart..vertex in 2016 had 2 failed CF trials..it takes time find right dosing. The fact they chose to release data early, instead wait another 12 weeks, means they are confident they found possibly the right dosing and feel they achieved their goals 👇
  • 1
  • 18